STOCK TITAN

Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

(Neutral)
(Very Positive)
Tags

Shoulder Innovations (NYSE:SI), a commercial-stage medical technology company focused on shoulder surgical care, announced that its management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, June 9, 2026.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus May 27 session
-0.60% close to close Open Argus
Details

News Market Reaction – SI

On May 27, the first trading day after this news, SI closed 0.60% below the previous close.

Data tracked by StockTitan Argus for the May 27 session.

Market Context

This announcement highlights Shoulder Innovations’ participation in a major healthcare conference, s...
Analysis

This announcement highlights Shoulder Innovations’ participation in a major healthcare conference, signaling continued engagement with the investment and medical communities. It follows recent quarters of strong revenue growth, margin improvement, and expanded product offerings in shoulder arthroplasty. Investors may contextualize this event alongside prior earnings, commercial launches, governance changes, and regulatory filings, focusing on how future updates on revenue, cash balance, and product adoption track against raised 2026 guidance.

Key Figures

Conference edition: 47th Conference date: June 9, 2026 Current price: $14.60 +1 more
Conference edition
47th
Goldman Sachs Annual Global Healthcare Conference
Conference date
June 9, 2026
Scheduled participation date in Miami Beach, FL
Current price
$14.60
Pre-news market context
1-day change
-3.31%
Price change over prior 24 hours

Historical Context

5 past events · Latest: May 13
5 events
  1. May 13

    Q1 2026 earnings

    24h Move
    +15.2%

    Strong Q1 revenue growth, margin expansion, and raised 2026 outlook.

  2. Apr 27

    Product launch

    24h Move
    +4.3%

    Full commercial launch of InSet I-135RFX humeral stem with expanded use.

  3. Apr 22

    Earnings date notice

    24h Move
    -4.5%

    Announcement of timing for Q1 2026 financial results and call.

  4. Mar 10

    FY 2025 earnings

    24h Move
    +7.4%

    Strong Q4 and full-year 2025 revenue growth with 2026 guidance issued.

  5. Mar 2

    Board change

    24h Move
    -0.2%

    Appointment of medtech veteran to board and related director resignation.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

GRAND RAPIDS, Mich., May 26, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, June 9, 2026.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations' ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact 
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference-302782176.html

SOURCE Shoulder Innovations

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Shoulder Innovations (NYSE:SI) participate in the Goldman Sachs 47th Annual Global Healthcare Conference?

Shoulder Innovations management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026. According to the company, the event will take place in Miami Beach, Florida, and feature healthcare-focused corporate presentations and meetings.

Where is the Goldman Sachs 47th Annual Global Healthcare Conference featuring Shoulder Innovations being held?

The Goldman Sachs 47th Annual Global Healthcare Conference featuring Shoulder Innovations will be held in Miami Beach, Florida. According to the company, members of management are scheduled to participate on Tuesday, June 9, 2026, alongside other healthcare organizations and investors.

What type of company is Shoulder Innovations (NYSE:SI) attending the Goldman Sachs healthcare conference?

Shoulder Innovations is a commercial-stage medical technology company focused exclusively on transforming the shoulder surgical care market. According to the company, its management’s participation in the Goldman Sachs 47th Annual Global Healthcare Conference underscores its positioning within the broader healthcare and medtech sector.

Why is Shoulder Innovations (SI) participating in the Goldman Sachs 47th Annual Global Healthcare Conference 2026?

Shoulder Innovations is participating in the Goldman Sachs 47th Annual Global Healthcare Conference to engage with the healthcare investment community. According to the company, members of management will take part in the Miami Beach event on June 9, 2026, as a commercial-stage medtech business.

Keep reading